Interstitial lung diseases (ILD) in children represent a heterogeneous group of rare and not well defined disorders. Genetic abnormalities of surfactant proteins B (SFTPB) and more recently C (SFTPC) have been shown to be related to these pathologies. However, variability in the lung disease phenotype suggests the involvement of other surfactant-associated genes such as ABCA3 (ATP-binding cassette, sub-family A, member, 3). Thus, the aim of this project is: 1) to assess the prevalence of SFTPC mutation in children with chronic lung diseases, 2) to precise clinical and radiological features of children with SFTPC mutation, and 3) to identify environmental or genetic factors that may explain the extreme variability of this disease.
The first stage of this project will be to constitute a clinical, radiological, biological database of children (1 moth-17 years) with severe respiratory distress and/or an unexplained chronic ILD. Mutations in SFTPC, SFTPB and ABCA3 will be further identified by sequencing and documented with using the parents blood samples.
Study Type
OBSERVATIONAL
Enrollment
58
2 ml of whole blood for children 5 ml of whole blood for parents that will be used only if 1 mutation is found in children
Hopital Trousseau
Paris, France
To assess the prevalence of SFTPC mutation in children with chronic lung diseases
Time frame: At the inclusion visit
To precise clinical and radiological features of children with SFTPC mutation
Time frame: At the inclusion visit
To identify environmental or genetic factors that may explain the extreme variability of this disease
Time frame: At the inclusion visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.